[{"text": "Gary E. Swan, PhD, Jennifer B.", "labels": [], "entities": []}, {"text": "McClure, PhD, Lisa M. Jack, MA, Susan M. Zbikowski, PhD, Harold S. Javitz, PhD, Sheryl L. Catz, PhD, Mona Deprey, MS, Julie Richards, MPH, Timothy A.", "labels": [], "entities": []}, {"text": "Background: Smoking remains the primary preventable cause of death and illness in the U.S. Effective, convenient treatment programs are needed to reduce smoking prevalence.", "labels": [], "entities": [{"text": "Smoking remains the primary preventable cause of death and illness", "start_pos": 12, "end_pos": 78, "type": "5.1_Information_about_health_consequences", "confidence": 0.7804992944002151}]}, {"text": "Purpose: This study compared the effectiveness of three modalities of a behavioral smokingcessation program in smokers using varenicline.", "labels": [], "entities": []}, {"text": "Methods: Current treatment-seeking smokers (n = 1202) were recruited from a large healthcare organization between October 2006 and October 2007.", "labels": [], "entities": []}, {"text": "Eligible participants were randomized to one of three smokingcessationinterventions: web-based counseling (n=401); proactive telephone-based counseling (PTC; n=402); or combined PTC and web counseling (n=399).", "labels": [], "entities": []}, {"text": "All participants received a standard 12 - week FDA-approved course of varenicline.", "labels": [], "entities": []}, {"text": "Self-report determined the primary outcomes (7 - day point prevalent abstinence at 3- and 6 - month follow-ups); the number of days varenicline was taken; and treatment-related symptoms.", "labels": [], "entities": [{"text": "Self-report", "start_pos": 0, "end_pos": 11, "type": "Self_report", "confidence": 0.9506267309188843}, {"text": "6", "start_pos": 90, "end_pos": 91, "type": "Longest_follow_up", "confidence": 0.9820829629898071}]}, {"text": "Behavioral measures determined utilization of both the web- and Phone-based counseling.", "labels": [], "entities": []}, {"text": "Results: Intent-to-treat analyses revealed relatively high percentages of abstinence at 3 months (38.9%, 48.5%, 43.4%) and at 6 months (30.7%, 34.3%, 33.8%) for the web, PTC, and PTC-web groups, respectively.", "labels": [], "entities": []}, {"text": "The PTC group had a significantly higher percentage of abstinence than the web group at 3 months (OR= 1.48,95% CI= 1.12,1.96), but no between-group differences in abstinence outcomes were seen at 6 months.", "labels": [], "entities": [{"text": "PTC group", "start_pos": 4, "end_pos": 13, "type": "Arm_name", "confidence": 0.798273891210556}, {"text": "OR", "start_pos": 98, "end_pos": 100, "type": "Odds_Ratio", "confidence": 0.9150070548057556}]}, {"text": "Conclusions: Phone counseling had greater treatment advantage for early cessation and appeared to increase medication adherence, but the absence of differences at 6 months suggests that any of the interventions hold promise when used in conjunction with varenicline.", "labels": [], "entities": []}, {"text": "(Am J Prev Med 2010;38(5):482 - 490) \u00a9 2010 American Journal of Preventive Medicine", "labels": [], "entities": []}, {"text": "roactive telephone counseling (PTC) is a popular mode of delivery of behavioral counseling for smoking cessation.", "labels": [], "entities": []}, {"text": "Its advantages include convenience and interpersonal contact, and its effectiveness is well documented.1,2 Delivery of health information and behavioral counseling for smoking cessation via webbased platforms is also becoming increasingly available, and several real-world evaluations of online cessation services3 - 5 and randomized trials of web-based services6 - 10 have been reported.", "labels": [], "entities": []}, {"text": "Most of these studies6,9,10 demonstrate that web-based delivery is effective.", "labels": [], "entities": []}, {"text": "The combination of PTC and web-based delivery could result in better", "labels": [], "entities": []}, {"text": "From SRI International (Swan, Jack, Javitz), Menlo Park, California; Group Health Research Institute (McClure, Catz, Richards); and Free & Clear, Inc.", "labels": [], "entities": []}, {"text": "(Zbikowski, Deprey, McAfee), Seattle, Washington", "labels": [], "entities": [{"text": "Seattle, Washington", "start_pos": 29, "end_pos": 48, "type": "Lower-level_geographical_region", "confidence": 0.8529860575993856}]}, {"text": "Address correspondence to: Gary E. Swan, PhD, Center for Health Sciences, SRI International, 333 Ravenswood Avenue, Menlo Park CA 94025.", "labels": [], "entities": [{"text": "Ravenswood Avenue", "start_pos": 97, "end_pos": 114, "type": "Lower-level_geographical_region", "confidence": 0.9008896350860596}, {"text": "Menlo Park CA", "start_pos": 116, "end_pos": 129, "type": "Lower-level_geographical_region", "confidence": 0.8601090510686239}]}, {"text": "E-mail: gary.swan@sri.com.", "labels": [], "entities": []}, {"text": "abstinence outcomes than either delivery method alone.", "labels": [], "entities": []}, {"text": "For example, PTC could be reinforced and supplemented by content on the web that is available to smokers at any time.", "labels": [], "entities": []}, {"text": "Information entered by the smoker online and sections visited could help tailor future counseling interactions.", "labels": [], "entities": []}, {"text": "However, prior research has not examined the potential synergy of combining PTC and web-based treatment.", "labels": [], "entities": []}, {"text": "At the time the present study was being designed, varenicline (aka Chantix\u00ae), an a4fi2 partial agonist that reduces the effects of withdrawal while also temporarily reducing the reinforcing effects of nicotine through stimulation of the dopaminergic reward pathway, had just been approved by the FDA.", "labels": [], "entities": []}, {"text": "Evidence in support of varenicline's efficacy is derived entirely from Phase-211 - 13 and standard-duration Phase-314 - 18 randomized placebo-controlled trials that also provided concomitant face-to-face behavioral counseling.", "labels": [], "entities": []}, {"text": "Compared to placebo, varenicline resulted in a significantly higherbiochemically confirmed abstinence percentage at 6 months (33.2% vs. 13.8 for placebo) following cessation.2 The extent to which varenicline is effective under more real-world (i.e., less-", "labels": [], "entities": []}, {"text": "\u00a9 2010 American Journal of Preventive Medicine \u2022 Published by Elsevier Inc.", "labels": [], "entities": []}, {"text": "Swan et al / Am J PrevMed 2010;38(5):482 - 490", "labels": [], "entities": []}, {"text": "controlled) conditions or in conjunction with counseling delivered via PTC or the web remains to be determined.", "labels": [], "entities": []}, {"text": "The primary objective of this randomized investigation was to determine the relative effectiveness of a widely used and empirically supported smoking-cessation pro- gram19 - 21 that was delivered three ways in a real-world setting: as standard PTC, via a newly developed web-based mode of delivery translated from the existing PTC program, and as a combined PTC- and web-based program.", "labels": [], "entities": []}, {"text": "It was hypothesized that the combined PTC- and web-based condition would result in the highest percentage of abstinence at the 6 - month follow-up, as it offers both interpersonal contact and greater availability, and that the web condition would result in a 6 - month abstinence percentage that was equivalent to that observed for the PTC condition.", "labels": [], "entities": []}, {"text": "Given recent concerns about potential side effects among people taking varenicline,22 a secondary aim was to report on symptoms and other events reported by participants in each of the three treatment groups.", "labels": [], "entities": []}, {"text": "Also provided are data on the effectiveness of varenicline when paired with various behavioral treatment programs and offered in a real-world setting.", "labels": [], "entities": []}, {"text": "Group Health, headquartered in Seattle WA, is a consumer-governed nonprofit healthcare organization that serves approximately 600,000 residents of Washington and Idaho.", "labels": [], "entities": [{"text": "Seattle WA", "start_pos": 31, "end_pos": 41, "type": "Lower-level_geographical_region", "confidence": 0.9463352262973785}, {"text": "Washington", "start_pos": 147, "end_pos": 157, "type": "Lower-level_geographical_region", "confidence": 0.9912931323051453}, {"text": "Idaho.", "start_pos": 162, "end_pos": 168, "type": "Lower-level_geographical_region", "confidence": 0.915171355009079}]}, {"text": "All protocols were reviewed and approved by the IRBs of Group Health, SRI International, and Free & Clear, Inc., as well as by a study Data and Safety Monitoring Board.", "labels": [], "entities": []}, {"text": "Participants were recruited from October 2006 to October 2007 through health plan magazine advertisements, employee mailings, physician referrals, and through Free & Clear's Quit For Life\u00ae Program.", "labels": [], "entities": []}, {"text": "Smokers were eligible if they were aged >18 years; had smoked at least 10 cigarettes per day during the past year and five cigarettes per day within the past week; had dependable telephone and Internet access and were comfortable using the Internet; were eligible for smoking-cessation services under current health plan coverage; and were medically appropriate for varenicline use.", "labels": [], "entities": []}, {"text": "Because participants did not see a study physician in person and received their prescription medication by mail, the exclusion criteria were more conservative than what is recommended in the varenicline prescribing information.2 Individuals were excluded from participation for any of the following: current/planned pregnancy or breast feeding; self-report of poor health, severe chronic heart disease, or chronic obstructive pulmonary disease; on dialysis or with certain kidney disease; current treatment for or self-report of schizophrenia, bipolar disorder, or mania; high-frequency alcohol use over the past 6 months (more than two drinks per day almost every day) and/or binge drinking two or more times in the past month; current use of bupropion, nicotine replacement therapy (NRT), investigational or recre- ational/street drugs; or use of cimetidine, metformin, phenformin, pindolol, or procainamide (drugs that could potentially interfere with renal clearance of varenicline23).", "labels": [], "entities": []}, {"text": "Eligible volunteers were interviewed by phone at intake to assess smoking history, including the Fagerstrom Test for Nicotine Dependence24; quitting history; motivation to quit; psychosocial characteristics, including (1) items from the Perceived Stress Scale,25 (2) depression history assessed using an item reflecting the two hallmark symptoms of major depression described in the DSM-IV,26 and (3) current depressive symptoms assessed using a brief measure derived from the Hopkins Symptom Checklist27; and demographics.", "labels": [], "entities": []}, {"text": "Telephone follow-up surveys were conducted by non-intervention study staff approximately 3 and 6 months after the target quit date to collect information on quit attempts, smoking, and medication use.", "labels": [], "entities": [{"text": "6", "start_pos": 95, "end_pos": 96, "type": "Longest_follow_up", "confidence": 0.9519280791282654}]}, {"text": "At 3 months, participants were also asked if during the past month they experienced any of a number of symptoms including probable medication side effects (obtained from the Chantix prescribing information) and nicotine abstinence effects.28 For each symptom experienced, the participant rated its severity on a 5 - point scale as follows: 1 = very mild, 2 = mild, 3 = moderate, 4=severe, and 5 = very severe.", "labels": [], "entities": []}, {"text": "Participants were randomized to treatment at the end ofthe Intake Survey.", "labels": [], "entities": []}, {"text": "Group assignment was randomly allocated using an automated algorithm built into the study database.", "labels": [], "entities": []}, {"text": "No restrictions such as stratification or blocking were used as part of the randomization process, and participants and study staff were not blinded to treatment assignment.", "labels": [], "entities": []}, {"text": "The three behavioral interventions were delivered by Free & Clear.", "labels": [], "entities": []}, {"text": "The PTC condition was the original Free & Clear Quit For Life program,19 - 21,29 - 31 and the web and PTC-web components were developed to replicate the principles and components of the PTC-based Quit For Life program.", "labels": [], "entities": []}, {"text": "Once screened and randomized, all participants received a 5- to 10minute orientation call, printed Quit Guides, and access to a toll- free in-bound support line for ad hoc calls.", "labels": [], "entities": []}, {"text": "Other services varied by intervention group.", "labels": [], "entities": []}, {"text": "PTC participants received up to five one-on- one proactive phone counseling sessions initiated by a Free & Clear tobacco treatment counselor (see Figure 1).", "labels": [], "entities": []}, {"text": "Participants in the web-based condition had access to the online program, which contained standardized content and interactive tools.", "labels": [], "entities": []}, {"text": "PTC-web participants received access to both programs, and the counselors had access to information participants entered online.", "labels": [], "entities": []}, {"text": "The proactive counseling calls provided practical expert support to help participants develop problem-solving and coping skills, secure social support, and design a plan for successful cessation and longterm abstinence.", "labels": [], "entities": []}, {"text": "Calls were scheduled at times convenient for the participant and at relapse-sensitive intervals.", "labels": [], "entities": []}, {"text": "Counselors used motivational interviewing techniques to elicit each participant's agenda for the call.", "labels": [], "entities": []}, {"text": "The web-based intervention contained interactive tools modified from those used in the PTC intervention.", "labels": [], "entities": []}, {"text": "Tailored content was based on where the participant was in the quit process.", "labels": [], "entities": []}, {"text": "Key features included an interactive quit plan, educational content in an online library, a quit calendar, cost calculator and progress tracker, a tool to email to friends and family for support, and active discussion forums to interact with other members.", "labels": [], "entities": []}, {"text": "During the PTC-web proactive calls, the treatment counselor encouraged participants to use the website for additional information and social support and to track the number of cigarettes smoked per day.", "labels": [], "entities": [{"text": "social support and to track the number of cigarettes smoked", "start_pos": 134, "end_pos": 193, "type": "2.3_Self-monitoring_of_behavior", "confidence": 0.7379102438688279}]}, {"text": "For PTC-web participants, the treatment counselors were able to see Quit Status, last login, and last use of the", "labels": [], "entities": []}, {"text": "Free & Clear proactive phone calls (PTC groups only)", "labels": [], "entities": []}, {"text": "P2: target quit day (TQD) call", "labels": [], "entities": []}, {"text": "P3: maintenance call (7 days after P2)", "labels": [], "entities": []}, {"text": "P4: maintenance call (21 days after P3)", "labels": [], "entities": []}, {"text": "P5: maintenance Call (21 days after P4)", "labels": [], "entities": []}, {"text": "Login information given during orientation call", "labels": [], "entities": []}, {"text": "12 - week prescription, starting 7 days before TQD", "labels": [], "entities": []}, {"text": "Intake Follow-up 1 Follow-up 2 Follow-up 3", "labels": [], "entities": []}, {"text": "Follow-up 1: first follow-up call (21 days after TQD) Follow-up 2: second follow-up call (3 months after TQD) Follow-up 3: third follow-up call (6 months after TQD)", "labels": [], "entities": []}, {"text": "pants in all three treatment groups received a prescrip\u00ac", "labels": [], "entities": []}, {"text": "tion for a 12 - week supply of", "labels": [], "entities": []}, {"text": "prior to the quit date.", "labels": [], "entities": []}, {"text": "dition to material packaged with the medication, Free", "labels": [], "entities": []}, {"text": "Utilization of behavioral programs was summarized into two global measures: number of contacts (phone calls completed plus website logins) and total minutes (sum of minutes spent on the phone and the website).", "labels": [], "entities": []}, {"text": "Phone minutes included all minutes spent on proactive and ad hoc telephone calls, and website minutes were collected automatically via a web activity tracker.", "labels": [], "entities": []}, {"text": "To remove the influence of a few very large outliers, total contacts and contact duration were truncated based on visual inspection of the data by the study biostatistician.", "labels": [], "entities": []}, {"text": "These truncated values fell between the 95th and 99th percentiles for each measure.", "labels": [], "entities": []}, {"text": "Utilization of medication is summarized as proportion of pills taken during the treatment phase (a 5 - point scale from 1 = none to 5=all) as well as by the total number of days varenicline was taken.", "labels": [], "entities": []}, {"text": "Abstinence was defined as the self-report of no smoking, not even a puff, within the past 7 or 30 days (i.e., 7- and 30 - day point prevalent abstinence).", "labels": [], "entities": [{"text": "self-report", "start_pos": 30, "end_pos": 41, "type": "Self_report", "confidence": 0.9626010656356812}, {"text": "30", "start_pos": 117, "end_pos": 119, "type": "Longest_follow_up", "confidence": 0.9200262427330017}]}, {"text": "Using an intention-to-treat approach, individuals who were not reached for follow-up were considered to be smoking.", "labels": [], "entities": []}, {"text": "Based on prior experience with Free & Clear PTC in this population, it was assumed that the PTC-onlytreatment wouldbe 32.3% abstinent at follow-up.", "labels": [], "entities": []}, {"text": "Having 400 participants per treatment arm would provide 80% power to distinguish a difference in abstinence percentage at follow-up between the PTC-only and the web or the combined PTC- web groups of roughly 9.9% (i.e., up to 42.2% or down to 23.1%).", "labels": [], "entities": []}, {"text": "Overall group differences on pretreatment characteristics and treatment utilization were examined using ANOVA (continu\u00ac", "labels": [], "entities": []}, {"text": "ous variables) or the chi-square test of equality of distributions (categoric variables).", "labels": [], "entities": []}, {"text": "Pairwise comparisons between treatments on utilization variables were conducted while adjusting for multiple comparisons via the Tukey's honestly significant difference procedure.", "labels": [], "entities": []}, {"text": "Logistic regression analysis was used to evaluate the relationship of mode of counseling (web, PTC, PTC-web) to smoking outcome at each follow-up point, both with and without relevant covariates (see Table 1).", "labels": [], "entities": []}, {"text": "For analysis of intake predictors of abstinence at 3 and 6 months, only those variables with p-values less than 0.25 in an initial full model with all intake predictors were included in the models shown in Table 5.", "labels": [], "entities": []}, {"text": "A total of 2093 screening interviews were conducted.", "labels": [], "entities": []}, {"text": "The 2093 screened volunteers were, on average, aged 47.5 (\u00b111.5) years, smoked 20.6 (\u00b18.9) cigarettes per day in the past year, and were 64.6% female.", "labels": [], "entities": [{"text": "47.5", "start_pos": 52, "end_pos": 56, "type": "Mean_age", "confidence": 0.9731907248497009}, {"text": "20.6", "start_pos": 79, "end_pos": 83, "type": "Mean_number_of_times_tobacco_used", "confidence": 0.4480851888656616}, {"text": "64.6", "start_pos": 137, "end_pos": 141, "type": "Proportion_identifying_as_female_gender", "confidence": 0.270561158657074}]}, {"text": "Overall, 804 (31.2%) volunteers were excluded from participation in the current study, with the most common reasons being computer-related (lack of Internet or e-mail access; 20% of 804) followed by too few cigarettes smoked per day (14%); excessive daily alcohol use or binge drinking (14%); current use of a contraindicated medication (recreational or prescribed; 13%); the lack of proper coverage under the volunteer's insurance plan (12%); and ineligibility for smoking-cessation services (12%).", "labels": [], "entities": []}, {"text": "Swan et al / Am J PrevMed 2010;38(5):482 - 490", "labels": [], "entities": []}, {"text": "Intake characteristics of the sample overall and by treatment group", "labels": [], "entities": []}, {"text": "The Characteristic: Overall (n=1202) of  has a value of Web (n=401).", "labels": [], "entities": []}, {"text": "The Characteristic: Overall (n=1202) of  has a value of PTC (n=402).", "labels": [], "entities": []}, {"text": "The Age (years) of Overall (n=1202): Demographics has a value of 47.3.", "labels": [], "entities": [{"text": "47.3", "start_pos": 65, "end_pos": 69, "type": "Mean_age", "confidence": 0.541898787021637}]}, {"text": "The Age (years) of  has a value of 47.1.", "labels": [], "entities": [{"text": "47.1", "start_pos": 35, "end_pos": 39, "type": "Proportion_identifying_as_female_gender", "confidence": 0.3471830189228058}]}, {"text": "The Age (years) of  has a value of 47.0.", "labels": [], "entities": [{"text": "47.0", "start_pos": 35, "end_pos": 39, "type": "Proportion_identifying_as_female_gender", "confidence": 0.2716245949268341}]}, {"text": "The Age (years) of PTC-Web (n=399): Demographics has a value of 47.9.", "labels": [], "entities": [{"text": "47.9", "start_pos": 64, "end_pos": 68, "type": "Proportion_identifying_as_female_gender", "confidence": 0.45738205313682556}]}, {"text": "The Gender (% female) of Overall (n=1202): Demographics has a value of 66.9.", "labels": [], "entities": [{"text": "66.9", "start_pos": 71, "end_pos": 75, "type": "Proportion_identifying_as_female_gender", "confidence": 0.35673531889915466}]}, {"text": "The Gender (% female) of  has a value of 66.8.", "labels": [], "entities": [{"text": "66.8", "start_pos": 41, "end_pos": 45, "type": "Proportion_identifying_as_female_gender", "confidence": 0.25179970264434814}]}, {"text": "The Gender (% female) of  has a value of 65.2.", "labels": [], "entities": [{"text": "65.2", "start_pos": 41, "end_pos": 45, "type": "Proportion_identifying_as_female_gender", "confidence": 0.2724062502384186}]}, {"text": "The Gender (% female) of PTC-Web (n=399): Demographics has a value of 68.7.", "labels": [], "entities": [{"text": "68.7", "start_pos": 70, "end_pos": 74, "type": "Proportion_identifying_as_female_gender", "confidence": 0.34081849455833435}]}, {"text": "The Race (% white) of Overall (n=1202): Demographics has a value of 89.7a.", "labels": [], "entities": [{"text": "89.7a", "start_pos": 68, "end_pos": 73, "type": "Proportion_identifying_as_belonging_to_a_specific_ethnic_group", "confidence": 0.37281283736228943}]}, {"text": "The Race (% white) of  has a value of 91.7.", "labels": [], "entities": [{"text": "91.7", "start_pos": 38, "end_pos": 42, "type": "Proportion_identifying_as_belonging_to_a_specific_ethnic_group", "confidence": 0.6949819326400757}]}, {"text": "The Race (% white) of  has a value of 87.9.", "labels": [], "entities": [{"text": "87.9", "start_pos": 38, "end_pos": 42, "type": "Proportion_identifying_as_belonging_to_a_specific_ethnic_group", "confidence": 0.7058903574943542}]}, {"text": "The Race (% white) of PTC-Web (n=399): Demographics has a value of 89.4.", "labels": [], "entities": [{"text": "89.4", "start_pos": 67, "end_pos": 71, "type": "Proportion_identifying_as_belonging_to_a_specific_ethnic_group", "confidence": 0.7394140958786011}]}, {"text": "The Years of formal schooling of Overall (n=1202): Demographics has a value of 14.0.", "labels": [], "entities": []}, {"text": "The Years of formal schooling of  has a value of 14.0.", "labels": [], "entities": []}, {"text": "The Years of formal schooling of  has a value of 14.0.", "labels": [], "entities": []}, {"text": "The Years of formal schooling of PTC-Web (n=399): Demographics has a value of 14.1.", "labels": [], "entities": []}, {"text": "The Marital status (% married) of Overall (n=1202): Demographics has a value of 63.7.", "labels": [], "entities": [{"text": "63.7", "start_pos": 80, "end_pos": 84, "type": "Proportion_identifying_as_female_gender", "confidence": 0.28594961762428284}]}, {"text": "The Marital status (% married) of  has a value of 66.4.", "labels": [], "entities": [{"text": "66.4", "start_pos": 50, "end_pos": 54, "type": "Proportion_identifying_as_female_gender", "confidence": 0.28815650939941406}]}, {"text": "The Marital status (% married) of  has a value of 63.7.", "labels": [], "entities": [{"text": "63.7", "start_pos": 50, "end_pos": 54, "type": "Proportion_identifying_as_female_gender", "confidence": 0.320263534784317}]}, {"text": "The Marital status (% married) of PTC-Web (n=399): Demographics has a value of 61.0.", "labels": [], "entities": [{"text": "61.0", "start_pos": 79, "end_pos": 83, "type": "Proportion_identifying_as_female_gender", "confidence": 0.27480223774909973}]}, {"text": "The BMI (kg/m2) of Overall (n=1202): Demographics has a value of 27.8.", "labels": [], "entities": []}, {"text": "The BMI (kg/m2) of  has a value of 27.9.", "labels": [], "entities": [{"text": "27.9", "start_pos": 35, "end_pos": 39, "type": "Mean_number_of_times_tobacco_used", "confidence": 0.4429076910018921}]}, {"text": "The BMI (kg/m2) of  has a value of 27.7.", "labels": [], "entities": [{"text": "27.7", "start_pos": 35, "end_pos": 39, "type": "Mean_number_of_times_tobacco_used", "confidence": 0.4119121730327606}]}, {"text": "The BMI (kg/m2) of PTC-Web (n=399): Demographics has a value of 27.7.", "labels": [], "entities": []}, {"text": "The Cigarettes per day of Overall (n=1202): Demographics has a value of 19.7.", "labels": [], "entities": [{"text": "19.7", "start_pos": 72, "end_pos": 76, "type": "Mean_number_of_times_tobacco_used", "confidence": 0.7885384559631348}]}, {"text": "The Cigarettes per day of  has a value of 19.8.", "labels": [], "entities": [{"text": "19.8", "start_pos": 42, "end_pos": 46, "type": "Mean_number_of_times_tobacco_used", "confidence": 0.7613694667816162}]}, {"text": "The Cigarettes per day of  has a value of 19.5.", "labels": [], "entities": [{"text": "19.5", "start_pos": 42, "end_pos": 46, "type": "Mean_number_of_times_tobacco_used", "confidence": 0.67853182554245}]}, {"text": "The Cigarettes per day of PTC-Web (n=399): Demographics has a value of 19.8.", "labels": [], "entities": [{"text": "19.8", "start_pos": 71, "end_pos": 75, "type": "Mean_number_of_times_tobacco_used", "confidence": 0.830991804599762}]}, {"text": "The FTND of Overall (n=1202): Demographics has a value of 4.9.", "labels": [], "entities": []}, {"text": "The FTND of  has a value of 4.9.", "labels": [], "entities": []}, {"text": "The FTND of  has a value of 4.8.", "labels": [], "entities": []}, {"text": "The FTND of PTC-Web (n=399): Demographics has a value of 5.0.", "labels": [], "entities": []}, {"text": "The Other smokers in home (% yes) of Overall (n=1202): Demographics has a value of 44.1.", "labels": [], "entities": []}, {"text": "The Other smokers in home (% yes) of  has a value of 47.4.", "labels": [], "entities": []}, {"text": "The Other smokers in home (% yes) of  has a value of 41.5.", "labels": [], "entities": []}, {"text": "The Other smokers in home (% yes) of PTC-Web (n=399): Demographics has a value of 43.4.", "labels": [], "entities": []}, {"text": "The Quit attempt past year (% yes) of Overall (n=1202): Demographics has a value of 48.3.", "labels": [], "entities": []}, {"text": "The Quit attempt past year (% yes) of  has a value of 46.3.", "labels": [], "entities": []}, {"text": "The Quit attempt past year (% yes) of  has a value of 49.9.", "labels": [], "entities": []}, {"text": "The Quit attempt past year (% yes) of PTC-Web (n=399): Demographics has a value of 48.6.", "labels": [], "entities": []}, {"text": "The Longest previous quit of >6 months (% yes) of Overall (n=1202): Demographics has a value of 36.7.", "labels": [], "entities": []}, {"text": "The Longest previous quit of >6 months (% yes) of  has a value of 36.7.", "labels": [], "entities": [{"text": "36.7", "start_pos": 66, "end_pos": 70, "type": "Outcome_value", "confidence": 0.7153958082199097}]}, {"text": "The Longest previous quit of >6 months (% yes) of  has a value of 35.1.", "labels": [], "entities": [{"text": "35.1", "start_pos": 66, "end_pos": 70, "type": "Outcome_value", "confidence": 0.7107042074203491}]}, {"text": "The Longest previous quit of >6 months (% yes) of PTC-Web (n=399): Demographics has a value of 38.2.", "labels": [], "entities": []}, {"text": "The Previous use of NRT (% yes) of Overall (n=1202): Demographics has a value of 82.5.", "labels": [], "entities": [{"text": "82.5", "start_pos": 81, "end_pos": 85, "type": "Proportion_identifying_as_belonging_to_a_specific_ethnic_group", "confidence": 0.49729564785957336}]}, {"text": "The Previous use of NRT (% yes) of  has a value of 80.8.", "labels": [], "entities": []}, {"text": "The Previous use of NRT (% yes) of  has a value of 83.6.", "labels": [], "entities": [{"text": "83.6", "start_pos": 51, "end_pos": 55, "type": "Proportion_identifying_as_belonging_to_a_specific_ethnic_group", "confidence": 0.4063519239425659}]}, {"text": "The Previous use of NRT (% yes) of PTC-Web (n=399): Demographics has a value of 83.2.", "labels": [], "entities": [{"text": "83.2", "start_pos": 80, "end_pos": 84, "type": "Proportion_identifying_as_belonging_to_a_specific_ethnic_group", "confidence": 0.5023351907730103}]}, {"text": "The Previous use of bupropion (% yes) of Overall (n=1202): Demographics has a value of 48.4.", "labels": [], "entities": []}, {"text": "The Previous use of bupropion (% yes) of  has a value of 49.0.", "labels": [], "entities": []}, {"text": "The Previous use of bupropion (% yes) of  has a value of 47.9.", "labels": [], "entities": []}, {"text": "The Previous use of bupropion (% yes) of PTC-Web (n=399): Demographics has a value of 48.5.", "labels": [], "entities": []}, {"text": "The Motivated to quit (% extremely) of Overall (n=1202): Demographics has a value of 69.0.", "labels": [], "entities": []}, {"text": "The Motivated to quit (% extremely) of  has a value of 66.5.", "labels": [], "entities": []}, {"text": "The Motivated to quit (% extremely) of  has a value of 70.2.", "labels": [], "entities": []}, {"text": "The Motivated to quit (% extremely) of PTC-Web (n=399): Demographics has a value of 70.2.", "labels": [], "entities": []}, {"text": "The Confident in success (% extremely) of Overall (n=1202): Demographics has a value of 35.5.", "labels": [], "entities": []}, {"text": "The Confident in success (% extremely) of  has a value of 34.5.", "labels": [], "entities": []}, {"text": "The Confident in success (% extremely) of  has a value of 36.9.", "labels": [], "entities": []}, {"text": "The Confident in success (% extremely) of PTC-Web (n=399): Demographics has a value of 35.0.", "labels": [], "entities": []}, {"text": "The Perceived stress of Overall (n=1202): Demographics has a value of 7.6.", "labels": [], "entities": []}, {"text": "The Perceived stress of  has a value of 7.7.", "labels": [], "entities": []}, {"text": "The Perceived stress of  has a value of 7.7.", "labels": [], "entities": []}, {"text": "The Perceived stress of PTC-Web (n=399): Demographics has a value of 7.5.", "labels": [], "entities": []}, {"text": "The Depression scale of Overall (n=1202): Demographics has a value of 0.9.", "labels": [], "entities": []}, {"text": "The Depression scale of  has a value of 0.9.", "labels": [], "entities": []}, {"text": "The Depression scale of  has a value of 0.9.", "labels": [], "entities": []}, {"text": "The Depression scale of PTC-Web (n=399): Demographics has a value of 0.9.", "labels": [], "entities": []}, {"text": "The Ever suffer from depression (% yes)b of Overall (n=1202): Demographics has a value of 56.2.", "labels": [], "entities": [{"text": "56.2", "start_pos": 90, "end_pos": 94, "type": "Proportion_identifying_as_female_gender", "confidence": 0.4753565192222595}]}, {"text": "The Ever suffer from depression (% yes)b of  has a value of 57.5.", "labels": [], "entities": [{"text": "57.5", "start_pos": 60, "end_pos": 64, "type": "Mean_age", "confidence": 0.47395583987236023}]}, {"text": "The Ever suffer from depression (% yes)b of  has a value of 59.9.", "labels": [], "entities": []}, {"text": "The Ever suffer from depression (% yes)b of PTC-Web (n=399): Demographics has a value of 51.0.", "labels": [], "entities": [{"text": "51.0", "start_pos": 89, "end_pos": 93, "type": "Proportion_identifying_as_female_gender", "confidence": 0.30585044622421265}]}, {"text": "The % of family ever depressed of Overall (n=1202): Demographics has a value of 19.1.", "labels": [], "entities": []}, {"text": "The % of family ever depressed of  has a value of 19.3.", "labels": [], "entities": []}, {"text": "The % of family ever depressed of  has a value of 19.5.", "labels": [], "entities": []}, {"text": "The % of family ever depressed of PTC-Web (n=399): Demographics has a value of 18.3.", "labels": [], "entities": []}, {"text": "The % of family ever smoked of Overall (n=1202): Demographics has a value of 52.0.", "labels": [], "entities": [{"text": "52.0", "start_pos": 77, "end_pos": 81, "type": "Proportion_identifying_as_female_gender", "confidence": 0.32285889983177185}]}, {"text": "The % of family ever smoked of  has a value of 52.8.", "labels": [], "entities": []}, {"text": "The % of family ever smoked of  has a value of 51.1.", "labels": [], "entities": []}, {"text": "The % of family ever smoked of PTC-Web (n=399): Demographics has a value of 52.1.", "labels": [], "entities": [{"text": "52.1", "start_pos": 76, "end_pos": 80, "type": "Proportion_identifying_as_female_gender", "confidence": 0.3097659945487976}]}, {"text": "Note: Values are means unless otherwise indicated.", "labels": [], "entities": []}, {"text": "aRemaining racial categories include American Indian/Alaska Native (0.9%); Asian (1.0%); black (3.7%); Pacific Islander (1.0%); and more than one race (3.7%).", "labels": [], "entities": []}, {"text": "N=13 (1.0%) declined to state their race.", "labels": [], "entities": [{"text": "13", "start_pos": 2, "end_pos": 4, "type": "Individual-level_analysed", "confidence": 0.5343875288963318}]}, {"text": "bThe three treatment groups were similar on all characteristics listed except Ever suffer from depression (y2(2)=6.7, p=0.04).", "labels": [], "entities": []}, {"text": "FTND, Fagerstrom Test of Nicotine Dependence; NRT, nicotine replacement therapy; PTC, proactive telephonebased counseling", "labels": [], "entities": []}, {"text": "igible volunteers were similar to those who were excluded with respect to number of cigarettes smoked per day at screening (20.9 vs. 20.3), eligible volunteers were younger (46.8 vs. 48.8 years, p<0.0001) and more likely to be female (66.9% vs. 60.9%, p=0.006).", "labels": [], "entities": []}, {"text": "Consent was received and intake surveys completed for 1202 volunteers (93.3% of all eligible to participate; Figure 2).", "labels": [], "entities": [{"text": "1202", "start_pos": 54, "end_pos": 58, "type": "Individual-level_analysed", "confidence": 0.440655916929245}]}, {"text": "The characteristics of the resulting sample overall and by treatment group are shown in Table 1.", "labels": [], "entities": []}, {"text": "A total of 917 (76.3%) were reached for the 3 - month interview, and 892 (74.2%)", "labels": [], "entities": []}, {"text": "were reached for the 6 - month interview.", "labels": [], "entities": []}, {"text": "There were no differences in participation percentages among the three treatment groups at either time point.", "labels": [], "entities": []}, {"text": "Pairwise comparisons revealed that the total number of contacts varied significantly across treatment groups (see Table 2), with the PTC-web group having a higher average number than either of the other two treatments (vs. web, p<0.05; vs. PTC, p<0.05).", "labels": [], "entities": [{"text": "0.05", "start_pos": 247, "end_pos": 251, "type": "Effect_size_p_value", "confidence": 0.9146697521209717}]}, {"text": "Total contact duration in minutes was significantly lower for the PTC and web groups than for the PTC-web group (vs. web, p<0.05; vs. PTC, p<0.05).", "labels": [], "entities": [{"text": "0.05", "start_pos": 141, "end_pos": 145, "type": "Effect_size_p_value", "confidence": 0.9057058095932007}]}, {"text": "The PTC group reported a significantly larger number of days taken varenicline than did the other two groups (vs. web, p<0.05; vs. PTC-web, p<0.05) and a significantly higher proportion of pills taken than did the web group (p=0.02).", "labels": [], "entities": [{"text": "0.02", "start_pos": 227, "end_pos": 231, "type": "Effect_size_p_value", "confidence": 0.8419777750968933}]}, {"text": "Participants did use the option to call in for support across the three treatment conditions.", "labels": [], "entities": []}, {"text": "There were no differences among the three treatment groups regarding the number (percentage) who made one or more of these ad hoc calls: web, 128 (32.1%); PTC, 126 (31.4%); and PTC-web, 144 (36.1%).", "labels": [], "entities": []}, {"text": "For those who made these calls, the average number made was similar across the groups: web, 1.6; PTC, 1.4; andPTC-web, 1.6.", "labels": [], "entities": []}, {"text": "Swan et al / Am J PrevMed 2010;38(5):482 - 490", "labels": [], "entities": []}, {"text": "Note: After treatment assignment, some participants did not participate in the behavioral interventions.", "labels": [], "entities": []}, {"text": "A few who had participated did not set a target date to quit smoking, one of the required steps to initiate the varenicline prescription.", "labels": [], "entities": [{"text": "set a target date to quit", "start_pos": 35, "end_pos": 60, "type": "1.1.Goal_setting_(behavior)", "confidence": 0.8087602456410726}, {"text": "smoking", "start_pos": 61, "end_pos": 68, "type": "Smoking", "confidence": 0.700982928276062}]}, {"text": "* Not attempted: Because the timing for interviews was based on the target quit date, no attempt was made to contact participants at 3 months if they had not set a quit date (n=33).", "labels": [], "entities": [{"text": "target quit date", "start_pos": 68, "end_pos": 84, "type": "1.1.Goal_setting_(behavior)", "confidence": 0.8133857250213623}]}, {"text": "Other participants were not attempted for interviews if they had requested no further participation (n=16 at 3 months, n=48 at 6 months) or had passed away (n=1 at each time point).", "labels": [], "entities": []}, {"text": "At the 3 - month interview, a total of 582 participants (64%) in\u00ac", "labels": [], "entities": [{"text": "582", "start_pos": 39, "end_pos": 42, "type": "Individual-level_analysed", "confidence": 0.5821697115898132}]}, {"text": "dicated they were not taking the medication.", "labels": [], "entities": []}, {"text": "Participants could endorse any number of reasons for stopping, which included experience of treatment- related symptoms", "labels": [], "entities": []}, {"text": "(39%); running out of pills (33%); feeling they did not need it (24%); feeling it was not working (8%); and other (26%).", "labels": [], "entities": []}, {"text": "There were no group differences for no longer taking the medication or rea\u00ac", "labels": [], "entities": []}, {"text": "high percentages of 7 - day point prevalence abstinence at 3 and 6 months (see Table 3).", "labels": [], "entities": [{"text": "6", "start_pos": 65, "end_pos": 66, "type": "Longest_follow_up", "confidence": 0.9445361495018005}]}, {"text": "Pairwise comparisons revealed that the PTC group had a significantly higher abstinence percentage than the web group at 3 months, OR= 1.48,95% CI = 1.12,1.96, but no group differences were seen at 6 months.", "labels": [], "entities": [{"text": "PTC group", "start_pos": 39, "end_pos": 48, "type": "Arm_name", "confidence": 0.8479377329349518}, {"text": "OR", "start_pos": 130, "end_pos": 132, "type": "Odds_Ratio", "confidence": 0.9348222613334656}]}, {"text": "A similar pattern was seen for 30 - day point preva\u00ac", "labels": [], "entities": []}, {"text": "An examination of mean symptom severity ratings by type of counseling was also conducted in two groups: those who reported not smoking but still taking varenicline at the time of the 3 - month interview (for probable side effects; n=227) and those who reported not smoking but no longer taking varenicline (for probable abstinence effects; n=296).", "labels": [], "entities": [{"text": "296", "start_pos": 342, "end_pos": 345, "type": "Individual-level_analysed", "confidence": 0.6741460561752319}]}, {"text": "The percentages of people surveyed at 3 months who experienced any of the listed symptoms are shown in Table 4.", "labels": [], "entities": []}, {"text": "The most frequently reported symptom across all participants was the desire to smoke, which was also the most likely to be rated as higher in intensity.", "labels": [], "entities": []}, {"text": "The Characteristic of  has a value of Web (n=401).", "labels": [], "entities": []}, {"text": "The Characteristic of  has a value of PTC (n=402).", "labels": [], "entities": []}, {"text": "The Number of contacts of  has a value of 5.2a (5.0).", "labels": [], "entities": []}, {"text": "The Number of contacts of  has a value of 4.1b(1.7).", "labels": [], "entities": []}, {"text": "The Number of contacts of PTC-Web (n=399): Behavioral treatment has a value of 6.6c (4.4).", "labels": [], "entities": []}, {"text": "The Number of contacts of Overall comparison p-value: Behavioral treatment has a value of <0.0001.", "labels": [], "entities": [{"text": "0.0001", "start_pos": 91, "end_pos": 97, "type": "Effect_size_p_value", "confidence": 0.8555281758308411}]}, {"text": "The Contact duration in minutes of  has a value of 67.9a (68.2).", "labels": [], "entities": []}, {"text": "The Contact duration in minutes of  has a value of 67.5a (29.9).", "labels": [], "entities": []}, {"text": "The Contact duration in minutes of PTC-Web (n=399): Behavioral treatment has a value of 100.2 (62.6).", "labels": [], "entities": []}, {"text": "The Contact duration in minutes of Overall comparison p-value: Behavioral treatment has a value of <0.0001.", "labels": [], "entities": [{"text": "0.0001", "start_pos": 100, "end_pos": 106, "type": "Effect_size_p_value", "confidence": 0.8788965344429016}]}, {"text": "The Number of days varenicline taken of  has a value of 60.0b (35.7).", "labels": [], "entities": []}, {"text": "The Number of days varenicline taken of  has a value of 67.7 (31.2).", "labels": [], "entities": []}, {"text": "The Number of days varenicline taken of PTC-Web (n=399): Behavioral treatment has a value of 61.5a (32.7).", "labels": [], "entities": []}, {"text": "The Number of days varenicline taken of Overall comparison p-value: Behavioral treatment has a value of <0.007.", "labels": [], "entities": [{"text": "0.007", "start_pos": 105, "end_pos": 110, "type": "Effect_size_p_value", "confidence": 0.79203861951828}]}, {"text": "The Number of pills taken (% most or all) of  has a value of 71.2a.", "labels": [], "entities": []}, {"text": "The Number of pills taken (% most or all) of  has a value of 79.1b.", "labels": [], "entities": []}, {"text": "The Number of pills taken (% most or all) of PTC-Web (n=399): Behavioral treatment has a value of 73.8a,bc.", "labels": [], "entities": []}, {"text": "Note: Number of contacts=total completed phone calls+web logins; Contact duration=total minutes spent on the phone or on the website.", "labels": [], "entities": []}, {"text": "Values are M (SD) unless otherwise stated.", "labels": [], "entities": []}, {"text": "a,b,cPairwise comparisons: means that have no superscript in common are significantly different from each other (Tukey's honestly significant difference, p<0.05), superscripts generated at www.jerrydallal.com/ LHSP/similar_prog.htm.", "labels": [], "entities": [{"text": "0.05", "start_pos": 156, "end_pos": 160, "type": "Effect_size_p_value", "confidence": 0.8810628056526184}]}, {"text": "Swan et al / Am J PrevMed 2010;38(5):482 - 490", "labels": [], "entities": []}, {"text": "Seven- and 30 - day point prevalence abstinence at 3 and 6 months by treatment group", "labels": [], "entities": [{"text": "30", "start_pos": 11, "end_pos": 13, "type": "Longest_follow_up", "confidence": 0.9163408279418945}, {"text": "6", "start_pos": 57, "end_pos": 58, "type": "Longest_follow_up", "confidence": 0.9521074295043945}]}, {"text": "The Web of 7 - day, %: 3 months has a value of 38.9.", "labels": [], "entities": []}, {"text": "The Web of OR (95% CI) for comparison to web: 3 months has a value of .", "labels": [], "entities": []}, {"text": "The Web of OR (95% CI) for comparison to PTC: 3 months has a value of .", "labels": [], "entities": []}, {"text": "The PTC of 7 - day, %: 3 months has a value of 48.5.", "labels": [], "entities": []}, {"text": "The PTC of OR (95% CI) for comparison to web: 3 months has a value of 1.48 (1.12, 1.96)*.", "labels": [], "entities": [{"text": "1.48", "start_pos": 70, "end_pos": 74, "type": "Effect_size_estimate", "confidence": 0.9719680547714233}]}, {"text": "The PTC of OR (95% CI) for comparison to PTC: 3 months has a value of .", "labels": [], "entities": []}, {"text": "The PTC-web of 7 - day, %: 3 months has a value of 43.4.", "labels": [], "entities": []}, {"text": "The PTC-web of OR (95% CI) for comparison to web: 3 months has a value of 1.20 (0.91, 1.59).", "labels": [], "entities": [{"text": "1.20", "start_pos": 74, "end_pos": 78, "type": "Effect_size_estimate", "confidence": 0.97580885887146}]}, {"text": "The PTC-web of OR (95% CI) for comparison to PTC: 3 months has a value of 0.81 (0.62, 1.07).", "labels": [], "entities": []}, {"text": "The Web of 7 - day, %: 3 months has a value of 30.7.", "labels": [], "entities": []}, {"text": "The Web of OR (95% CI) for comparison to web: 3 months has a value of .", "labels": [], "entities": []}, {"text": "The Web of OR (95% CI) for comparison to PTC: 3 months has a value of .", "labels": [], "entities": []}, {"text": "The PTC of 7 - day, %: 3 months has a value of 34.3.", "labels": [], "entities": []}, {"text": "The PTC of OR (95% CI) for comparison to web: 3 months has a value of 1.18 (0.86, 1.56).", "labels": [], "entities": [{"text": "1.18", "start_pos": 70, "end_pos": 74, "type": "Effect_size_estimate", "confidence": 0.9719126224517822}]}, {"text": "The PTC of OR (95% CI) for comparison to PTC: 3 months has a value of .", "labels": [], "entities": []}, {"text": "The PTC-web of 7 - day, %: 3 months has a value of 33.8.", "labels": [], "entities": []}, {"text": "The PTC-web of OR (95% CI) for comparison to web: 3 months has a value of 1.16 (0.88, 1.59).", "labels": [], "entities": [{"text": "1.16", "start_pos": 74, "end_pos": 78, "type": "Effect_size_estimate", "confidence": 0.9730649590492249}]}, {"text": "The PTC-web of OR (95% CI) for comparison to PTC: 3 months has a value of 0.98 (0.73, 1.31).", "labels": [], "entities": []}, {"text": "The Web of 7 - day, %: 3 months has a value of 32.7.", "labels": [], "entities": []}, {"text": "The Web of OR (95% CI) for comparison to web: 3 months has a value of .", "labels": [], "entities": []}, {"text": "The Web of OR (95% CI) for comparison to PTC: 3 months has a value of .", "labels": [], "entities": []}, {"text": "The PTC of 7 - day, %: 3 months has a value of 42.0.", "labels": [], "entities": []}, {"text": "The PTC of OR (95% CI) for comparison to web: 3 months has a value of 1.50(1.12, 1.99)*.", "labels": [], "entities": [{"text": "1.50", "start_pos": 70, "end_pos": 74, "type": "Effect_size_estimate", "confidence": 0.9739018082618713}]}, {"text": "The PTC of OR (95% CI) for comparison to PTC: 3 months has a value of .", "labels": [], "entities": []}, {"text": "The PTC-web of 7 - day, %: 3 months has a value of 39.1.", "labels": [], "entities": []}, {"text": "The PTC-web of OR (95% CI) for comparison to web: 3 months has a value of 1.32 (0.99, 1.77).", "labels": [], "entities": [{"text": "1.32", "start_pos": 74, "end_pos": 78, "type": "Effect_size_estimate", "confidence": 0.9687023758888245}]}, {"text": "The PTC-web of OR (95% CI) for comparison to PTC: 3 months has a value of 0.88 (0.67, 1.17).", "labels": [], "entities": []}, {"text": "The Web of 7 - day, %: 3 months has a value of 27.4.", "labels": [], "entities": []}, {"text": "The Web of OR (95% CI) for comparison to web: 3 months has a value of .", "labels": [], "entities": []}, {"text": "The Web of OR (95% CI) for comparison to PTC: 3 months has a value of .", "labels": [], "entities": []}, {"text": "The PTC of 7 - day, %: 3 months has a value of 30.6.", "labels": [], "entities": []}, {"text": "The PTC of OR (95% CI) for comparison to web: 3 months has a value of 1.17 (0.86, 1.58).", "labels": [], "entities": [{"text": "1.17", "start_pos": 70, "end_pos": 74, "type": "Effect_size_estimate", "confidence": 0.973803699016571}]}, {"text": "The PTC of OR (95% CI) for comparison to PTC: 3 months has a value of .", "labels": [], "entities": []}, {"text": "The PTC-web of 7 - day, %: 3 months has a value of 30.3.", "labels": [], "entities": []}, {"text": "The PTC-web of OR (95% CI) for comparison to web: 3 months has a value of 1.15 (0.85, 1.56).", "labels": [], "entities": [{"text": "1.15", "start_pos": 74, "end_pos": 78, "type": "Effect_size_estimate", "confidence": 0.9706172347068787}]}, {"text": "The PTC-web of OR (95% CI) for comparison to PTC: 3 months has a value of 0.99 (0.73, 1.33).", "labels": [], "entities": []}, {"text": "Type ofbehavioral counseling did not significantly influence mean severity ratings of the six probable drug side effects.", "labels": [], "entities": []}, {"text": "Of the nine probable abstinence effects, only one was associated with form of counseling (change in appetite), with the PTC- web group reporting significantly higher average severity ratings than the web groups (p<0.05; data not shown).", "labels": [], "entities": []}, {"text": "Predictors of Abstinence at 3 and 6 Months", "labels": [], "entities": []}, {"text": "Table 5 presents results of the analysis of prediction of subsequent abstinence at 3 and 6 months by intake characteristics.", "labels": [], "entities": [{"text": "6", "start_pos": 89, "end_pos": 90, "type": "Longest_follow_up", "confidence": 0.967719316482544}]}, {"text": "Variables that were associated with abstinence at 3 months only included older age, and more years of formal education.", "labels": [], "entities": []}, {"text": "Lower levels of stress were associated with decreased risk for smoking at 6 months but not at 3 months.", "labels": [], "entities": []}, {"text": "Variables that were consistently predictive of abstinence atboth 3 and 6 months included having had a previous quit attempt that was longer than 6 months, lower levels of nicotine dependence, and a higher level of motivation to quit.", "labels": [], "entities": []}, {"text": "Although it was hypothesized that the PTC-web group would experience better 6 - month outcomes by virtue of the synergy", "labels": [], "entities": [{"text": "PTC-web group", "start_pos": 38, "end_pos": 51, "type": "Arm_name", "confidence": 0.8238862156867981}]}, {"text": "between the two components, allowing participants access to online resources 24 hours a day 7 days a week did not seem to have any additive benefit.", "labels": [], "entities": []}, {"text": "The fact that the web and PTC groups experienced equivalent 6 - month outcomes was consistent with expectation.", "labels": [], "entities": []}, {"text": "A plausible explanation for the lack of significant differences among the three treatment groups at 6 months is that the content and treatment philosophy of all three behavioral programs were similar.", "labels": [], "entities": []}, {"text": "The web and PTC- web programs were designed to be comparable to the PTC program in order to determine whether mode of delivery influenced treatment outcomes.", "labels": [], "entities": []}, {"text": "The PTC program provided several of the proven aspects recommended by the PHS guidelines: social support, practical advice and support, and assistance with planning and developing problem-solving and coping skills.", "labels": [], "entities": []}, {"text": "The reported percentages of abstinence for all three forms of the behavioral treatment-varenicline combination were roughly three times higher than the 13.1% point estimate provided in Fiore et al. for PTC alone2 and are consistent with the self-reported percentage seen in a previous study21 of a behavioral treatment- bupropion combination in this setting (32.3%).", "labels": [], "entities": []}, {"text": "The 3 - month point prevalence abstinence percentage for the PTC condition (48.5%) is consistent with that reported by two Phase-3 trials (50.3%),14,15 and the 6 - month point prevalence abstinence outcomes for all treatment groups fall within the 95% CI for the abstinence percentage estimated from currently available data relevant to varenicline's biochemically confirmed efficacy (28.9%, 37.8%).2 Based on these observed abstinence outcomes, it is concluded that the percentages observed in the varenicline Phase-3 clinical trials are generalizable to real-world behavioral treatment settings under less-controlled conditions.", "labels": [], "entities": []}, {"text": "Swan et al / Am J PrevMed 2010;38(5):482 - 490", "labels": [], "entities": []}, {"text": "Overall symptom experience at 3 months (%)a", "labels": [], "entities": []}, {"text": "The Nausea of None: Probable side effects has a value of 64.8.", "labels": [], "entities": []}, {"text": "The Nausea of Mild: Probable side effects has a value of 16.2.", "labels": [], "entities": [{"text": "16.2", "start_pos": 57, "end_pos": 61, "type": "Mean_number_of_times_tobacco_used", "confidence": 0.35660627484321594}]}, {"text": "The Nausea of Moderate: Probable side effects has a value of 12.2.", "labels": [], "entities": [{"text": "12.2", "start_pos": 61, "end_pos": 65, "type": "Outcome_value", "confidence": 0.5505046248435974}]}, {"text": "The Nausea of Severe: Probable side effects has a value of 6.7.", "labels": [], "entities": []}, {"text": "The Vomiting of None: Probable side effects has a value of 92.5.", "labels": [], "entities": [{"text": "92.5", "start_pos": 59, "end_pos": 63, "type": "Proportion_identifying_as_belonging_to_a_specific_ethnic_group", "confidence": 0.4588029980659485}]}, {"text": "The Vomiting of Mild: Probable side effects has a value of 3.7.", "labels": [], "entities": []}, {"text": "The Vomiting of Moderate: Probable side effects has a value of 2.1.", "labels": [], "entities": []}, {"text": "The Vomiting of Severe: Probable side effects has a value of 1.7.", "labels": [], "entities": []}, {"text": "The Constipation of None: Probable side effects has a value of 73.5.", "labels": [], "entities": []}, {"text": "The Constipation of Mild: Probable side effects has a value of 12.3.", "labels": [], "entities": []}, {"text": "The Constipation of Moderate: Probable side effects has a value of 10.2.", "labels": [], "entities": [{"text": "10.2", "start_pos": 67, "end_pos": 71, "type": "Outcome_value", "confidence": 0.6317214965820312}]}, {"text": "The Constipation of Severe: Probable side effects has a value of 4.0.", "labels": [], "entities": []}, {"text": "The Flatulence of None: Probable side effects has a value of 52.5.", "labels": [], "entities": []}, {"text": "The Flatulence of Mild: Probable side effects has a value of 20.1.", "labels": [], "entities": [{"text": "20.1", "start_pos": 61, "end_pos": 65, "type": "Mean_number_of_times_tobacco_used", "confidence": 0.5902690887451172}]}, {"text": "The Flatulence of Moderate: Probable side effects has a value of 20.5.", "labels": [], "entities": [{"text": "20.5", "start_pos": 65, "end_pos": 69, "type": "Mean_number_of_times_tobacco_used", "confidence": 0.5540403127670288}]}, {"text": "The Flatulence of Severe: Probable side effects has a value of 6.9.", "labels": [], "entities": []}, {"text": "The Change in dreaming of None: Probable side effects has a value of 62.5.", "labels": [], "entities": []}, {"text": "The Change in dreaming of Mild: Probable side effects has a value of 12.0.", "labels": [], "entities": [{"text": "12.0", "start_pos": 69, "end_pos": 73, "type": "Outcome_value", "confidence": 0.6996925473213196}]}, {"text": "The Change in dreaming of Moderate: Probable side effects has a value of 15.5.", "labels": [], "entities": [{"text": "15.5", "start_pos": 73, "end_pos": 77, "type": "Outcome_value", "confidence": 0.7225431799888611}]}, {"text": "The Change in dreaming of Severe: Probable side effects has a value of 10.0.", "labels": [], "entities": [{"text": "10.0", "start_pos": 71, "end_pos": 75, "type": "Outcome_value", "confidence": 0.6675624251365662}]}, {"text": "The Change in taste perception of None: Probable side effects has a value of 62.3.", "labels": [], "entities": []}, {"text": "The Change in taste perception of Mild: Probable side effects has a value of 14.2.", "labels": [], "entities": [{"text": "14.2", "start_pos": 77, "end_pos": 81, "type": "Mean_number_of_times_tobacco_used", "confidence": 0.37956419587135315}]}, {"text": "The Change in taste perception of Moderate: Probable side effects has a value of 18.3.", "labels": [], "entities": [{"text": "18.3", "start_pos": 81, "end_pos": 85, "type": "Mean_number_of_times_tobacco_used", "confidence": 0.395285427570343}]}, {"text": "The Change in taste perception of Severe: Probable side effects has a value of 5.1.", "labels": [], "entities": []}, {"text": "The Difficulty sleeping of None: Probable side effects has a value of 59.5.", "labels": [], "entities": []}, {"text": "The Difficulty sleeping of Mild: Probable side effects has a value of 14.3.", "labels": [], "entities": []}, {"text": "The Difficulty sleeping of Moderate: Probable side effects has a value of 18.2.", "labels": [], "entities": [{"text": "18.2", "start_pos": 74, "end_pos": 78, "type": "Mean_number_of_times_tobacco_used", "confidence": 0.39164280891418457}]}, {"text": "The Difficulty sleeping of Severe: Probable side effects has a value of 8.0.", "labels": [], "entities": []}, {"text": "The Change in appetite of None: Probable side effects has a value of 65.4.", "labels": [], "entities": []}, {"text": "The Change in appetite of Mild: Probable side effects has a value of 11.9.", "labels": [], "entities": [{"text": "11.9", "start_pos": 69, "end_pos": 73, "type": "Outcome_value", "confidence": 0.5618975758552551}]}, {"text": "The Change in appetite of Moderate: Probable side effects has a value of 16.8.", "labels": [], "entities": [{"text": "16.8", "start_pos": 73, "end_pos": 77, "type": "Outcome_value", "confidence": 0.5767505764961243}]}, {"text": "The Change in appetite of Severe: Probable side effects has a value of 5.9.", "labels": [], "entities": []}, {"text": "The Desire to smoke of None: Probable side effects has a value of 26.1.", "labels": [], "entities": [{"text": "26.1", "start_pos": 66, "end_pos": 70, "type": "Mean_number_of_times_tobacco_used", "confidence": 0.7307683229446411}]}, {"text": "The Desire to smoke of Mild: Probable side effects has a value of 28.7.", "labels": [], "entities": [{"text": "28.7", "start_pos": 66, "end_pos": 70, "type": "Mean_number_of_times_tobacco_used", "confidence": 0.728527307510376}]}, {"text": "The Desire to smoke of Moderate: Probable side effects has a value of 26.7.", "labels": [], "entities": [{"text": "26.7", "start_pos": 70, "end_pos": 74, "type": "Mean_number_of_times_tobacco_used", "confidence": 0.70975261926651}]}, {"text": "The Desire to smoke of Severe: Probable side effects has a value of 18.4.", "labels": [], "entities": [{"text": "18.4", "start_pos": 68, "end_pos": 72, "type": "Mean_number_of_times_tobacco_used", "confidence": 0.7087684869766235}]}, {"text": "The Difficulty concentrating of None: Probable side effects has a value of 75.7.", "labels": [], "entities": []}, {"text": "The Difficulty concentrating of Mild: Probable side effects has a value of 13.0.", "labels": [], "entities": []}, {"text": "The Difficulty concentrating of Moderate: Probable side effects has a value of 8.8.", "labels": [], "entities": []}, {"text": "The Difficulty concentrating of Severe: Probable side effects has a value of 2.5.", "labels": [], "entities": []}, {"text": "The Tension/agitation of None: Probable side effects has a value of 61.1.", "labels": [], "entities": []}, {"text": "The Tension/agitation of Mild: Probable side effects has a value of 19.9.", "labels": [], "entities": [{"text": "19.9", "start_pos": 68, "end_pos": 72, "type": "Mean_number_of_times_tobacco_used", "confidence": 0.5760349631309509}]}, {"text": "The Tension/agitation of Moderate: Probable side effects has a value of 16.3.", "labels": [], "entities": [{"text": "16.3", "start_pos": 72, "end_pos": 76, "type": "Mean_number_of_times_tobacco_used", "confidence": 0.4161699712276459}]}, {"text": "The Tension/agitation of Severe: Probable side effects has a value of 2.8.", "labels": [], "entities": []}, {"text": "The Irritability/anger of None: Probable side effects has a value of 63.1.", "labels": [], "entities": []}, {"text": "The Irritability/anger of Mild: Probable side effects has a value of 18.3.", "labels": [], "entities": [{"text": "18.3", "start_pos": 69, "end_pos": 73, "type": "Mean_number_of_times_tobacco_used", "confidence": 0.46807166934013367}]}, {"text": "The Irritability/anger of Moderate: Probable side effects has a value of 14.5.", "labels": [], "entities": [{"text": "14.5", "start_pos": 73, "end_pos": 77, "type": "Outcome_value", "confidence": 0.48421502113342285}]}, {"text": "The Irritability/anger of Severe: Probable side effects has a value of 4.1.", "labels": [], "entities": []}, {"text": "The Depression of None: Probable side effects has a value of 74.8.", "labels": [], "entities": []}, {"text": "The Depression of Mild: Probable side effects has a value of 14.8.", "labels": [], "entities": []}, {"text": "The Depression of Moderate: Probable side effects has a value of 8.5.", "labels": [], "entities": []}, {"text": "The Depression of Severe: Probable side effects has a value of 2.0.", "labels": [], "entities": []}, {"text": "The Confusion of None: Probable side effects has a value of 86.8.", "labels": [], "entities": [{"text": "86.8", "start_pos": 60, "end_pos": 64, "type": "Proportion_identifying_as_belonging_to_a_specific_ethnic_group", "confidence": 0.5580541491508484}]}, {"text": "The Confusion of Mild: Probable side effects has a value of 8.4.", "labels": [], "entities": []}, {"text": "The Confusion of Moderate: Probable side effects has a value of 4.1.", "labels": [], "entities": []}, {"text": "The Confusion of Severe: Probable side effects has a value of 0.8.", "labels": [], "entities": []}, {"text": "The Anxiety of None: Probable side effects has a value of 69.4.", "labels": [], "entities": []}, {"text": "The Anxiety of Mild: Probable side effects has a value of 15.5.", "labels": [], "entities": []}, {"text": "The Anxiety of Moderate: Probable side effects has a value of 12.2.", "labels": [], "entities": []}, {"text": "The Anxiety of Severe: Probable side effects has a value of 2.9.", "labels": [], "entities": []}, {"text": "Note: Because the study design did not include a drug placebo condition, drug and abstinence side effects are considered probable.", "labels": [], "entities": []}, {"text": "aParticipants who did not experience a symptom were given the rating of none.", "labels": [], "entities": []}, {"text": "For display simplicity, very mild and mild categories were combined, as were the severe and very severe categories.", "labels": [], "entities": []}, {"text": "disturbances and abnormal dreams were the most likely symptoms to be rated as moderate or severe at the 3 - month inter\u00ac", "labels": [], "entities": []}, {"text": "view, similar to the proportion of study participants report\u00ac", "labels": [], "entities": []}, {"text": "ing side effects in the efficacy trials.", "labels": [], "entities": []}, {"text": "all, the type ofbehav- ioral counseling was not associated with severity ratings for", "labels": [], "entities": []}, {"text": "any of the symptoms assessed in the", "labels": [], "entities": []}, {"text": "showed that change in the severity of these symptoms also did not differ as a function of a self-re\u00ac", "labels": [], "entities": []}, {"text": "study, there were nine (0.8%) serious", "labels": [], "entities": []}, {"text": "adverse effects reported to the FDA, but none was considered likely to be causally related to varenicline use with the exception of a moderate allergic event that did not require medical attention.", "labels": [], "entities": []}, {"text": "An individual with an extensive psychiatric history undisclosed at study entry had a brief psychiatric hospitalization.", "labels": [], "entities": []}, {"text": "There were two cardiac deaths that occurred in participants with pre-existing cardiac disease and risk factors.", "labels": [], "entities": []}, {"text": "For both the cardiac deaths and the psychiatric hospitalization, a potentiating role of varenicline was considered unlikely.", "labels": [], "entities": []}, {"text": "Potential limitations of the study include its reliance on selfreport for medication adherence and smoking outcomes.", "labels": [], "entities": []}, {"text": "Because this open-label study was conducted in a real-world setting and used telephone and mailed interactions between study participants and project staff, more intensive monitoring was not feasible.", "labels": [], "entities": []}, {"text": "The finding that use of treatment regimens varied across treatment groups will need to be confirmed in subsequent studies.", "labels": [], "entities": []}, {"text": "The absence of biochemical confirmation may have resulted in an overestimation of the true abstinence percentage; however, previous analyses suggest that the amount of under-reporting of smoking in a large field trial of this type may be minimal.20,33 - 35 Moreover, all interventions examined in this trial can be described asbeing of \u201clow intensity.\u201d", "labels": [], "entities": []}, {"text": "no in-person visits and, at most, participants received five proactive call attempts.", "labels": [], "entities": []}, {"text": "There were no guarantees that the participants would take these calls or be fully engaged in treatment.", "labels": [], "entities": []}, {"text": "In addition, the self-reported smoking status used to document outcomes was provided by the participants to the Group Health Survey Research Program, an organization that is independent of the interventions provided by Free & Clear.", "labels": [], "entities": []}, {"text": "For these reasons, it is felt that the inherent demand of the assessment context would have had only minimal impact on the over-reporting of abstinence.", "labels": [], "entities": []}, {"text": "The lack of a no-medication control group limits the ability to draw conclusions about the effectiveness of these behavioral treatments without medication or to determine the true range of symptoms associated with varenicline use or nicotine withdrawal.", "labels": [], "entities": []}, {"text": "In addition, the systematic screening of all probable treatment-related symptoms endorsed at each follow-up is different from the method used to assess side effects in a standard clinical trial and could result in greater frequencies of some side effects than previously reported.", "labels": [], "entities": []}, {"text": "Although these results are consistent with those seen in the original Phase-3 clinical trials, the reader should remain cautious to not overgeneralize.", "labels": [], "entities": []}, {"text": "The individuals recruited for this trial were highly motivated and were offered behavioral", "labels": [], "entities": []}, {"text": "Swan et al / Am J PrevMed 2010;38(5):482 - 490", "labels": [], "entities": []}, {"text": "Predictors of 7 - day point prevalence abstinence at 3 and 6 months", "labels": [], "entities": [{"text": "6", "start_pos": 59, "end_pos": 60, "type": "Longest_follow_up", "confidence": 0.9634943604469299}]}, {"text": "The Older age (years)a of 3 months: p-value: Demographic has a value of 0.0438.", "labels": [], "entities": []}, {"text": "The Older age (years)a of 3 months: OR (95% CI): Demographic has a value of 1.13 (1.00, 1.27).", "labels": [], "entities": []}, {"text": "The Older age (years)a of 6 months: p-value: Demographic has a value of 0.1476.", "labels": [], "entities": []}, {"text": "The Older age (years)a of 6 months: OR (95% CI): Demographic has a value of 1.10 (0.97, 1.24).", "labels": [], "entities": []}, {"text": "The Male gender of 3 months: p-value: Demographic has a value of 0.4388.", "labels": [], "entities": []}, {"text": "The Male gender of 3 months: OR (95% CI): Demographic has a value of 1.10 (0.86, 1.42).", "labels": [], "entities": []}, {"text": "The Male gender of 6 months: p-value: Demographic has a value of 0.1341.", "labels": [], "entities": []}, {"text": "The Male gender of 6 months: OR (95% CI): Demographic has a value of 1.22 (0.94, 1.59).", "labels": [], "entities": []}, {"text": "The More years of formal schoolinga of 3 months: p-value: Demographic has a value of 0.0060.", "labels": [], "entities": []}, {"text": "The More years of formal schoolinga of 3 months: OR (95% CI): Demographic has a value of 1.18 (1.05, 1.33).", "labels": [], "entities": [{"text": "1.18", "start_pos": 89, "end_pos": 93, "type": "Effect_size_estimate", "confidence": 0.9710412621498108}]}, {"text": "The More years of formal schoolinga of 6 months: p-value: Demographic has a value of 0.0991.", "labels": [], "entities": []}, {"text": "The More years of formal schoolinga of 6 months: OR (95% CI): Demographic has a value of 1.11 (0.98, 1.26).", "labels": [], "entities": [{"text": "1.11", "start_pos": 89, "end_pos": 93, "type": "Effect_size_estimate", "confidence": 0.9741787314414978}]}, {"text": "The Lower FTNDa of 3 months: p-value: Demographic has a value of 0.0011.", "labels": [], "entities": []}, {"text": "The Lower FTNDa of 3 months: OR (95% CI): Demographic has a value of 1.23 (1.08, 1.39).", "labels": [], "entities": [{"text": "1.23", "start_pos": 69, "end_pos": 73, "type": "Effect_size_estimate", "confidence": 0.9823777675628662}]}, {"text": "The Lower FTNDa of 6 months: p-value: Demographic has a value of 0.0018.", "labels": [], "entities": []}, {"text": "The Lower FTNDa of 6 months: OR (95% CI): Demographic has a value of 1.23(1.08, 1.39).", "labels": [], "entities": [{"text": "1.23", "start_pos": 69, "end_pos": 73, "type": "Effect_size_estimate", "confidence": 0.9828821420669556}]}, {"text": "The No other smokers in home: \u2014: \u2014 of 6 months: p-value: Demographic has a value of 0.2456.", "labels": [], "entities": []}, {"text": "The No other smokers in home: \u2014: \u2014 of 6 months: OR (95% CI): Demographic has a value of 1.16 (0.90, 1.49).", "labels": [], "entities": [{"text": "1.16", "start_pos": 88, "end_pos": 92, "type": "Effect_size_estimate", "confidence": 0.9724259376525879}]}, {"text": "The Previous use of bupropion: \u2014: \u2014 of 6 months: p-value: Demographic has a value of 0.1667.", "labels": [], "entities": []}, {"text": "The Previous use of bupropion: \u2014: \u2014 of 6 months: OR (95% CI): Demographic has a value of 1.19 (0.93, 1.53).", "labels": [], "entities": [{"text": "1.19", "start_pos": 89, "end_pos": 93, "type": "Effect_size_estimate", "confidence": 0.9788275361061096}]}, {"text": "The Previous quit attempt >6 months of 3 months: p-value: Demographic has a value of 0.0084.", "labels": [], "entities": [{"text": "0.0084", "start_pos": 85, "end_pos": 91, "type": "Effect_size_p_value", "confidence": 0.5417174696922302}]}, {"text": "The Previous quit attempt >6 months of 3 months: OR (95% CI): Demographic has a value of 1.39 (1.09, 1.78).", "labels": [], "entities": [{"text": "1.39", "start_pos": 89, "end_pos": 93, "type": "Effect_size_estimate", "confidence": 0.985031247138977}]}, {"text": "The Previous quit attempt >6 months of 6 months: p-value: Demographic has a value of 0.0156.", "labels": [], "entities": [{"text": "0.0156", "start_pos": 85, "end_pos": 91, "type": "Effect_size_p_value", "confidence": 0.5331675410270691}]}, {"text": "The Previous quit attempt >6 months of 6 months: OR (95% CI): Demographic has a value of 1.37 (1.06, 1.77).", "labels": [], "entities": [{"text": "1.37", "start_pos": 89, "end_pos": 93, "type": "Effect_size_estimate", "confidence": 0.984307050704956}]}, {"text": "The Quit attempt 24 - hour past year of 3 months: p-value: Demographic has a value of 0.1468.", "labels": [], "entities": []}, {"text": "The Quit attempt 24 - hour past year of 3 months: OR (95% CI): Demographic has a value of 1.19 (0.94, 1.51).", "labels": [], "entities": [{"text": "1.19", "start_pos": 90, "end_pos": 94, "type": "Effect_size_estimate", "confidence": 0.9852755069732666}]}, {"text": "The Higher motivation to quita of 3 months: p-value: Demographic has a value of 0.0030.", "labels": [], "entities": []}, {"text": "The Higher motivation to quita of 3 months: OR (95% CI): Demographic has a value of 1.20 (1.06, 1.36).", "labels": [], "entities": [{"text": "1.20", "start_pos": 84, "end_pos": 88, "type": "Effect_size_estimate", "confidence": 0.9860986471176147}]}, {"text": "The Higher motivation to quita of 6 months: p-value: Demographic has a value of 0.0176.", "labels": [], "entities": []}, {"text": "The Higher motivation to quita of 6 months: OR (95% CI): Demographic has a value of 1.17 (1.03, 1.34).", "labels": [], "entities": [{"text": "1.17", "start_pos": 84, "end_pos": 88, "type": "Effect_size_estimate", "confidence": 0.9859948754310608}]}, {"text": "The Lower perceived stressa of 3 months: p-value: Demographic has a value of 0.1167.", "labels": [], "entities": []}, {"text": "The Lower perceived stressa of 3 months: OR (95% CI): Demographic has a value of 1.10 (0.98, 1.25).", "labels": [], "entities": [{"text": "1.10", "start_pos": 81, "end_pos": 85, "type": "Effect_size_estimate", "confidence": 0.9849255681037903}]}, {"text": "The Lower perceived stressa of 6 months: p-value: Demographic has a value of 0.0180.", "labels": [], "entities": []}, {"text": "The Lower perceived stressa of 6 months: OR (95% CI): Demographic has a value of 1.17 (1.03, 1.34).", "labels": [], "entities": [{"text": "1.17", "start_pos": 81, "end_pos": 85, "type": "Effect_size_estimate", "confidence": 0.984282910823822}]}, {"text": "Note: Only one of two variables with high bivariate intercorrelations were selected for inclusion (e.g., cigarettes smoked per day and FTND, r =0.69).", "labels": [], "entities": []}, {"text": "To maximize the number of cases available to be included in the models to predict treatment outcome, multiple imputation was used to replace each missing value with a set of plausible values.", "labels": [], "entities": []}, {"text": "The multiply imputed data sets were then analyzed by using standard procedures.", "labels": [], "entities": []}, {"text": "aORs for continuous variables reflect a change of 1 SD.", "labels": [], "entities": []}, {"text": "FTND, Fagerstrom Test of Nicotine Dependence", "labels": [], "entities": []}, {"text": "Therefore, although the observed abstinence outcomes are closer to those expected in real-world applications similar to that seen in managed care, they are likely to be higher still than those seen in the general population for whom varenicline is prescribed for smoking cessation but no concomitant behavioral support is provided.", "labels": [], "entities": []}, {"text": "The present study reveals two important issues in nicotine addiction treatment.", "labels": [], "entities": []}, {"text": "First, that there were no differences in abstinence outcomes at 6 months suggests that any of the three programs offered here hold promise as alternative interventions in combination with varenicline.", "labels": [], "entities": []}, {"text": "Second, the current study provides important data regarding the use of varenicline in real-world settings and is responsive to the need for community-based trials involving varenicline.36,37 Use of varenicline in a real-world setting, with less-stringent eligibility criteria and less clinical follow-up than in the Phase-3 trials, still results in substantial abstinence outcomes when paired with behavioral intervention.", "labels": [], "entities": []}, {"text": "The authors acknowledge the following individuals who contributed substantially to this project: Gaye Courtney,", "labels": [], "entities": []}, {"text": "Lisa Nguyen, Shahab Kahn, and Martha Agreda for their efforts in screening and enrolling the participants in this study; Sal- lie Dacey, MD, for consultation on eligibility issues and medical chart review as needed; Jennifer Cinnamon for her diligent care and monitoring of trial participants and general assistance with myriad essential tasks throughout the study; Julia Anderson and Kati- eRose Oliver for their hard work and patience in managing the collection of the follow-up data; Ken Wassum, who was instrumental in developing protocols for varenicline treatment support and health event reporting; Jenny Hapgood for managing the development of the website; and Abigail Halperin, MD, for support of health event reporting and investigation.", "labels": [], "entities": []}, {"text": "The authors also acknowledge the consultative assistance of Drs.", "labels": [], "entities": []}, {"text": "Ray Niaura, Caryn Lerman, and Neal Benowitz, who served on the study's data and safety monitoring board.", "labels": [], "entities": []}, {"text": "This study was funded by the National Cancer Institute (Grant R01CA071358) and is registered at Clinicaltrials.gov (NCT00301145).", "labels": [], "entities": []}, {"text": "Varenicline and nominal support for recruiting participants was provided by Pfizer, Inc.", "labels": [], "entities": []}, {"text": "Neither entity had any role in the study design; the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.", "labels": [], "entities": []}, {"text": "Portions of this paper were presented to the annual meeting of the Society for Behavioral Medicine, Montreal, April 24, 2009.", "labels": [], "entities": []}, {"text": "SMZ owns stock in Free & Clear, Inc.; and GES received financial support from Pfizer to attend a 1 - day advisory meeting in 2008, and a small grant from Pfizer to support recruitment and study intake.", "labels": [], "entities": []}, {"text": "No other financial disclosures were reported by the authors of this paper.", "labels": [], "entities": []}, {"text": "Swan et al / Am J PrevMed 2010;38(5):482 - 490", "labels": [], "entities": []}]